Involvement of oxidative stress and mitochondrial dysfunction in the osmotic swelling of retinal glial cells from diabetic rats

Experimental Eye Research

Volumn 92, Issue 1, 2011, Pages 87-93

  Krügel, Katja ^a   Wurm, Antje ^a   Pannicke, Thomas ^a   Hollborn, Margrit ^a   Karl, Anett ^a   Wiedemann, Peter ^a   Reichenbach, Andreas ^a   Kohen, Leon ^a,b   Bringmann, Andreas ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HELIOS Klinikum Aue   (Germany)

Author keywords

Cytotoxic edema; Diabetic retinopathy; M ller glial cell; Rat; Retina

Indexed keywords

ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CYCLOSPORIN A; MINOCYCLINE; NITRIC OXIDE SYNTHASE; PERINDOPRIL; PINACIDIL; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y1 RECEPTOR ANTAGONIST; PURINERGIC RECEPTOR BLOCKING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOZOCIN; UNCLASSIFIED DRUG; XANTHINE OXIDASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; EYE SWELLING; GLIA CELL; HYPERGLYCEMIA; MITOCHONDRION SWELLING; MUELLER CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; MITOCHONDRIAL DISEASES; NADPH OXIDASE; NEUROGLIA; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RATS; RATS, LONG-EVANS; RECEPTOR, ADENOSINE A1; RETINAL NEURONS; XANTHINE OXIDASE;

EID: 78650540339     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.11.007     Document Type: Article

References (40)

1. Abu El-Asrar A.M., Desmet S., Meersschaert A., Dralands L., Missotten L., Geboes K. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am. J. Ophthalmol. 2001, 132:551-556.
2. Antcliff R.J., Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin. Ophthalmol. 1999, 14:223-232.
3. Beretta S., Wood J.P., Derham B., Sala G., Tremolizzo L., Ferrarese C., Osborne N.N. Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON). Neurobiol. Dis. 2006, 24:308-317.
4. Bresnick G.H. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 1983, 90:1301-1317.
5. Bringmann A., Reichenbach A., Wiedemann P. Pathomechanisms of cystoid macular edema. Ophthalmic Res. 2004, 36:241-249.
6. Bringmann A., Pannicke T., Grosche J., Francke M., Wiedemann P., Skatchkov S.N., Osborne N.N., Reichenbach A. Müller cells in the healthy and diseased retina. Prog. Retin. Eye Res. 2006, 25:397-424.
7. Bringmann A., Iandiev I., Pannicke T., Wurm A., Hollborn M., Wiedemann P., Osborne N.N., Reichenbach A. Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Prog. Retin. Eye Res. 2009, 28:423-451.
8. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 1988, 255:357-360.
9. Du Y., Miller C.M., Kern T.S. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic. Biol. Med. 2003, 35:1491-1499.
10. Fuks B., Talaga P., Huart C., Hénichart J.P., Bertrand K., Grimée R., Lorent G. In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone: a novel permeability transition pore inhibitor. Eur. J. Pharmacol. 2005, 519:24-30.
11. Gieseler A., Schultze A.T., Kupsch K., Haroon M.F., Wolf G., Siemen D., Kreutzmann P. Inhibitory modulation of the mitochondrial permeability transition by minocycline. Biochem. Pharmacol. 2009, 77:886-896.
12. Goldstein I.M., Ostwald P., Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res. 1996, 36:2979-2994.
13. Goureau O., Hicks D., Courtois Y., de Kozak Y. Induction and regulation of nitric oxide synthetase in retinal Müller glial cells. J. Neurochem. 1994, 63:310-317.
14. Hansson M.J., Morota S., Teilum M., Mattiasson G., Uchino H., Elmér E. Increased potassium conductance of brain mitochondria induces resistance to permeability transition by enhancing matrix volume. J. Biol. Chem. 2010, 285:741-750.
15. Haverkamp S., Kolb H., Cuenca N. Endothelial nitric oxide synthase (eNOS) is localized to Müller cells in all vertebrate retinas. Vision Res. 1999, 39:2299-2303.
16. Huxlin K.R. NADPH-diaphorase expression in neurons and glia of the normal adult rat retina. Brain Res. 1995, 692:195-206.
17. Jayakumar A.R., Rao K.V., Panickar K.S., Moriyama M., Reddy P.V., Norenberg M.D. Trauma-induced cell swelling in cultured astrocytes. J. Neuropathol. Exp. Neurol. 2008, 67:417-427.
18. Kashii S., Mandai M., Kikuchi M., Honda Y., Tamura Y., Kaneda K., Akaike A. Dual actions of nitric oxide in N-methyl-d-aspartate receptor-mediated neurotoxicity in cultured retinal neurons. Brain Res. 1996, 711:93-101.
19. Kobayashi M., Kuroiwa T., Shimokawa R., Okeda R., Tokoro T. Nitric oxide synthase expression in ischemic rat retinas. Jpn. J. Ophthalmol. 2000, 44:235-244.
20. Kowluru R.A. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid. Redox Signal. 2005, 7:1581-1587.
21. Kowluru R.A., Kowluru V., Xiong Y., Ho Y.S. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic. Biol. Med. 2006, 41:1191-1196.
22. Krügel K., Wurm A., Linnertz R., Pannicke T., Wiedemann P., Reichenbach A., Bringmann A. Erythropoietin inhibits osmotic swelling of retinal glial cells by Janus kinase and extracellular signal-regulated kinases1/2-mediated release of vascular endothelial growth factor. Neuroscience 2010, 165:1147-1158.
23. Larsen M., Wang M., Sander B. Overnight thickness variation in diabetic macular edema. Invest. Ophthalmol. Vis. Sci. 2005, 46:2313-2316.
24. Liepe B.A., Stone C., Koistinaho J., Copenhagen D.R. Nitric oxide synthase in Müller cells and neurons of salamander and fish retina. J. Neurosci. 1994, 14:7641-7654.
25. Madsen-Bouterse S.A., Kowluru R.A. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev. Endocr. Metab. Disord. 2008, 9:315-327.
26. Marmor M.F. Mechanisms of fluid accumulation in retinal edema. Doc. Ophthalmol. 1999, 97:239-249.
27. Mori F., Hikichi T., Takahashi J., Nagaoka T., Yoshida A. Dysfunction of active transport of blood-retinal barrier in patients with clinically significant macular edema in type 2 diabetes. Diabetes Care 2002, 25:1248-1249.
28. Pannicke T., Iandiev I., Uckermann O., Biedermann B., Kutzera F., Wiedemann P., Wolburg H., Reichenbach A., Bringmann A. A potassium channel-linked mechanism of glial cell swelling in the postischemic retina. Mol. Cell. Neurosci. 2004, 26:493-502.
29. Pannicke T., Iandiev I., Wurm A., Uckermann O., vom Hagen F., Reichenbach A., Wiedemann P., Hammes H.-P., Bringmann A. Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes 2006, 55:633-639.
30. Pazdro R., Burgess J.R. The role of vitamin E and oxidative stress in diabetes complications. Mech. Ageing Dev. 2010, 131:276-286.
31. Skatchkov S.N., Thomzig A., Eaton M.J., Biedermann B., Eulitz D., Bringmann A., Pannicke T., Veh R.W., Reichenbach A. Kir subfamily in frog retina: specific spatial distribution of Kir6.1 in glial (Müller) cells. Neuroreport 2001, 12:1437-1441.
32. Stokes K.Y., Clanton E.C., Russell J.M., Ross C.R., Granger D.N. NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circ. Res. 2001, 88:499-505.
33. Uckermann O., Iandiev I., Francke M., Franze K., Grosche J., Wolf S., Kohen L., Wiedemann P., Reichenbach A., Bringmann A. Selective staining by vital dyes of Müller glial cells in retinal wholemounts. Glia 2004, 45:59-66.
34. Uckermann O., Kutzera F., Wolf A., Pannicke T., Reichenbach A., Wiedemann P., Wolf S., Bringmann A. The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J. Pharmacol. Exp. Ther. 2005, 315:1036-1045.
35. Uckermann O., Wolf A., Kutzera F., Kalisch F., Beck-Sickinger A., Wiedemann P., Reichenbach A., Bringmann A. Glutamate release by neurons evokes a purinergic inhibitory mechanism of osmotic glial cell swelling in the rat retina: activation by neuropeptide Y. J. Neurosci. Res. 2006, 83:538-550.
36. Wurm A., Iandiev I., Hollborn M., Wiedemann P., Reichenbach A., Zimmermann H., Bringmann A., Pannicke T. Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina. Exp. Eye Res. 2008, 87:385-393.
37. Wurm A., Lipp S., Pannicke T., Linnertz R., Krügel U., Schulz A., Färber K., Zahn D., Grosse J., Wiedemann P., Chen J., Schöneberg T., Illes P., Reichenbach A., Bringmann A. Endogenous purinergic signaling is required for osmotic volume regulation of retinal glial cells. J. Neurochem. 2010, 112:1261-1272.
38. Zheng L., Kern T.S. Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front. Biosci. 2009, 14:3974-3987.
39. Zheng Z., Chen H., Ke G., Fan Y., Zou H., Sun X., Gu Q., Xu X., Ho P.C. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway. Diabetes 2009, 58:954-964.
40. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu D.C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2008, 417:74-78.